LA General) Rheumatology

Topics

• Systemic Lupus Erythematosus Research 103
• Rheumatoid Arthritis Research and Therapies 46
• T-cell and B-cell Immunology 43
• Monoclonal and Polyclonal Antibodies Research 21
• Hidradenitis Suppurativa and Treatments 17
• Inflammatory Myopathies and Dermatomyositis 11
• Gout, Hyperuricemia, Uric Acid 8
• Systemic Sclerosis and Related Diseases 8
• Immune Cell Function and Interaction 7
• Sarcoidosis and Beryllium Toxicity Research 7
• Vasculitis and related conditions 7
• Chronic Lymphocytic Leukemia Research 5

Most cited

1. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry.

   Annals of the rheumatic diseases · 2021 · 191 citations · Leanna Wise

2. Estimation of prevalence of autoimmune diseases in the United States using electronic health record data.

   The Journal of clinical investigation · 2024 · 60 citations · Stratos Christianakis, Leanna Wise

3. SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-Analysis.

   Arthritis & rheumatology (Hoboken, N.J.) · 2022 · 138 citations · Leanna Wise

4. Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial.

   Annals of the rheumatic diseases · 2021 · 125 citations · William Stohl

5. Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance.

   Annals of the rheumatic diseases · 2022 · 78 citations · Leanna Wise

6. A Randomized, Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings.

   Arthritis & rheumatology (Hoboken, N.J.) · 2023 · 46 citations · Dan La

7. Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.

   JAMA network open · 2021 · 100 citations · Leanna Wise

8. Underweight patients experience higher inpatient complication and mortality rates following acetabular fracture.

   European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2024 · 9 citations · Andrew Duong